Company Filing History:
Years Active: 2007-2017
Title: Innovations by Inventor David A. Eiznhamer
Introduction
David A. Eiznhamer is a notable inventor based in Bloomingdale, IL, recognized for his significant contributions to the field of pharmaceuticals. With a total of five patents to his name, Eiznhamer has made advancements that hold potential for treating various medical conditions through innovative compounds and methods.
Latest Patents
Eiznhamer's latest patents focus on the development of pyrazole derivatives as modulators of hepatocyte growth factor (HGF), commonly known as scatter factor activity. One of his prominent patents provides compounds that include specific pharmacological characteristics aimed at offering therapeutic benefits in the treatment of diseases where HGF/SF plays a vital role. Another of his recent inventions centers around small molecule modulators that engage with HGF activity, showcasing his commitment to medical innovation and patient care through these new compounds.
Career Highlights
Throughout his career, David A. Eiznhamer has been affiliated with Angion Biomedica Corporation, a company dedicated to advancing therapeutic solutions through targeted drug development. His work has not only contributed to the portfolio of patents at Angion but has also helped propel the company's mission within the biomedicine landscape.
Collaborations
Among David A. Eiznhamer's notable collaborations is his partnership with David E. Zembower. Together, they have combined their expertise to push the boundaries of pharmaceutical innovation, driving forward research that could have a significant impact on the medical field.
Conclusion
In summary, David A. Eiznhamer is a distinguished inventor whose work is instrumental in the advancement of therapeutic modalities. His patents, particularly in the realm of hepatocyte growth factor modulation, reflect a dedication to improving health outcomes and exemplify the innovative spirit that characterizes the field of biomedicine. As he continues to collaborate and innovate, Eiznhamer’s contributions will likely pave the way for more groundbreaking treatments in the future.